Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRIENDS-01: Romiplostim N01 vs rhIL-11 for Cancer Therapy-Induced Thrombocytopenia
NCT06759636Phase 3Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Feb 2025
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of romiplostim in Thrombocytopenia, sponsored by Jiangsu Provincial People's Hospital. Started Feb 2025; status: recruiting.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT06759636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06759636.